Capital Guardian Trust Co. lifted its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 25.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,796 shares of the company’s stock after acquiring an additional 2,396 shares during the quarter. Capital Guardian Trust Co.’s holdings in Express Scripts were worth $747,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Park National Corp OH grew its stake in Express Scripts by 0.3% during the second quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after purchasing an additional 11 shares during the period. Parkside Financial Bank & Trust grew its stake in Express Scripts by 0.3% during the second quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after purchasing an additional 23 shares during the period. CAPROCK Group Inc. grew its stake in Express Scripts by 0.9% during the second quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after purchasing an additional 33 shares during the period. Sandy Spring Bank grew its stake in Express Scripts by 0.6% during the second quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock worth $413,000 after purchasing an additional 37 shares during the period. Finally, Honkamp Krueger Financial Services Inc. grew its stake in Express Scripts by 0.8% during the second quarter. Honkamp Krueger Financial Services Inc. now owns 4,762 shares of the company’s stock worth $304,000 after purchasing an additional 38 shares during the period. Institutional investors own 88.44% of the company’s stock.

Several equities research analysts recently commented on the company. Sanford C. Bernstein raised Express Scripts from an “underperform” rating to a “market perform” rating in a research note on Wednesday, December 6th. TheStreet raised Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, December 4th. Deutsche Bank began coverage on Express Scripts in a research note on Monday, December 4th. They issued a “buy” rating and a $75.00 price objective for the company. Finally, Jefferies Group reissued a “buy” rating on shares of Express Scripts in a research note on Thursday, October 26th. Six research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $70.67.

In other news, CEO Timothy C. Wentworth bought 8,000 shares of the stock in a transaction on Tuesday, October 31st. The shares were purchased at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the completion of the purchase, the chief executive officer now directly owns 98,628 shares in the company, valued at approximately $6,029,129.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Phyllis S. Anderson sold 643 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. Insiders own 0.68% of the company’s stock.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) opened at $68.39 on Tuesday. The company has a market capitalization of $38,598.32, a price-to-earnings ratio of 9.96, a P/E/G ratio of 1.01 and a beta of 0.88. Express Scripts Holding Company has a fifty-two week low of $55.80 and a fifty-two week high of $73.52. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.90. The business had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. Express Scripts’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period last year, the company posted $1.74 earnings per share. analysts anticipate that Express Scripts Holding Company will post 7.01 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://www.dailypolitical.com/2017/12/12/capital-guardian-trust-co-has-747000-stake-in-express-scripts-holding-company-esrx.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.